J&J has announced that new preliminary results from a #SouthAfrican study has shown that the homologous booster shot of the company's #COVID19 vaccine demonstrated 85% effectiveness against the virus-related hospitalisation in S Africa after #Omicron became the dominant variant. pic.twitter.com/AwByaNSCmQ— IANS Tweets (@ians_india) December 31, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


